Rotorua Daily Post

Countries limit Astrazenec­a as regulators stress risk low

-

In Spain, residents now have to be over 60 to get an Astrazenec­a coronaviru­s vaccine. In Belgium, over 55. In Britain, authoritie­s recommend the shot not be given to adults under 30 where possible, and Australia’s Government announced similar limits yesterday to Astrazenec­a vaccinatio­ns for those under 50.

A patchwork of advice was emerging from Government­s around the world after the European Union’s drug regulator said there was a “possible link” between the Astrazenec­a vaccine and a rare clotting disorder while reiteratin­g the vaccine is safe and effective.

Regulators in Britain and the European Union both stressed that the risk is very low for most people, and the EU agency maintained its guidance that the vaccine can be used in all adults.

News of the tiny risk already is already having an effect. In Croatia, the Government said that one in four people due to get an Astrazenec­a vaccine yesterday didn’t show up. Poland, too, has also seen people cancel or not appear for appointmen­ts to get the vaccine. French general practition­er Dr Joel Valendoff said many of his patients were still coming to get their dose, but many others were cancelling.

Australian Prime Minister Scott Morrison, whose country’s vaccinatio­n programme leans heavily on Astrazenec­a’s vaccine, announced that the Pfizer vaccine should be adopted as the preferred vaccine for people under 50. “We’ve been taking the necessary precaution­s based on the best possible medical advice,” Morrison said. “It has not been our practice to jump at shadows.”

Newspapers in English

Newspapers from New Zealand